Synexus Chandler Site Number : 8400251 — Chandler, Arizona

Synexus Chandler Site Number : 8400251 is a clinical research site located in Chandler, Arizona, United States 85225.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Synexus Chandler Site Number : 8400251 has participated in 1 clinical trials.

Therapeutic areas: COVID-19.

Sponsors: Sanofi Pasteur, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chandler

Browse all research sites in Arizona · View every site in Chandler

• Chandler Regional Hospital
• GSK Investigational Site
• Research Site
• Radiant Research
• Ironwood Cancer Research Centers
• Arizona Eye Center
• Chandler Regional Medical Center
• Arizona Liver Health
• Chandler Clinical Trials
• Ironwood Cancer and Research Centers
• Pfizer Investigational Site
• Ironwood Cancer and Research Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Synexus Chandler Site Number : 8400251?

Synexus Chandler Site Number : 8400251 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Synexus Chandler Site Number : 8400251 conducted?

Synexus Chandler Site Number : 8400251 has 1 clinical trials on record. Their work covers COVID-19.

Is Synexus Chandler Site Number : 8400251 accredited by Crixeo Clinical Trials?

Synexus Chandler Site Number : 8400251 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Synexus Chandler Site Number : 8400251?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.